Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats

Acta Pharmacologica Sinica

Volumn 20, Issue 10, 1999, Pages 923-928

  Su, Jin Zi ^a   Chen, Song Cang ^a,b   Wu, Ke Gui ^a   Chen, Da Guang ^a   Rui, Hong Bing ^a   Wang, Xiang Yu ^a   Wang, Hua Jun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Hypertension; Inbred SHR rats; Left ventricular hypertrophy; Propranolol; Thiazide diuretics

Indexed keywords

COLLAGEN; HYDROCHLOROTHIAZIDE; PERINDOPRIL; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART WEIGHT; HYPERTENSION; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; DIURETICS; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PERINDOPRIL; PROPRANOLOL; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SODIUM CHLORIDE SYMPORTER INHIBITORS; VENTRICULAR REMODELING;

EID: 0032724956     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65.
2. Black MJ, Kanellakis P, Bobik A. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats. J Hypertens 1997; 15: 945-54.
3. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A metaanalysis of randomized double-blind studies. JAMA 1996; 275: 1507-13.
4. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-7.
5. Senior R, Imbs JL, Bory M, Amabile G, Denis B, Zannad F, et al. Indapamide reduces hypertensive left ventricular hypertrophy; an international multicenter study. J Cardiovasc Pharmacol 1993; 22 Suppl 6: S106-10.
6. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy: a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-55.
7. Chen SC, Chen DG, Jin XQ, Hu WY, Wang HJ. Mechanism to prevent genetic hypertension by early captopril treatment in spontaneously hypertensive rats. Chin J Pharmacol Toxicol 1995; 9: 175-9.
8. McLenachan JM, Dargie HJ. A review of rhythm disorders in cardiac hypertrophy. Am J Cardiol 1990; 65: 42G-44G.
9. Contard F, Glukhova M, Marotte F, Narcisse G, Schatz C, Swynghedauw B, et al. Diuretic effects on cardiac hypertrophy in the stroke prone spontaneously hypertensive rat. Cardiovasc Res 1993; 27: 429-34.
10. Moser M. Current hypertension management: separating fact from fiction. Cleve Clin J Med 1993; 60: 27-37.
11. Wada T, Sanada T, Ojima M, Kanagawa R, Nishikawa K, Inada Y. Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats. Hypertens Res 1996; 19: 247-54.
12. Carey PA, Sheridan DJ, de Cordoue A, Guez D. Effect of indapamide on left ventricular hypertrophy in hypertension; a meta-analysis. Am J Cardiol 1996; 77: 17B-19B.
13. Wang H, Delaney KH, Kwiecien JM, Smeda JS, Lee RM. Prevention of stroke with perindopril treatment in strokeprone spontaneously hypertensive rats. Clin Invest Med 1997; 20: 327-38.
14. Karam H, Heudes D, Hess P, Gonzales MF, Loffler BM, Clozel M, et al. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 1996; 31: 287-95.